Careers  |  Sign In  |  Register  |   Twitter

Latest in Business of Medicine

With well over 1,000 dead from the recent outbreak of the ebola virus, a financial incentive to find a treatment may be just what drugmakers need, an article published by NPR’s Shots Blog reveals. Everyone seems to be asking why there is no solution to this deadly virus, and the answer seems to boil...
In another attempt to curb the ever-increasing amount of prescription drug abuse, the U.S. government will tighten restrictions on hydrocodone, an opioid painkiller found in drugs such as Vicodin. According to an article published by Reuters, products containing hydrocodone with another substance will now be...
Sanofi has signed on with MannKind Corp. to purchase rights to Afrezza, the world’s first and only inhaled insulin product, an article published by Bloomberg News reports. MannKind Corp. will be paid $150 million up front, and as much as $925 million total for Afrezza, which received its FDA approval...